ScoreWhy is PharmaSGP Holding SE ?
1
Poor long term growth as Operating profit has grown by an annual rate 8.22% of over the last 5 years
2
With ROE of 40.70%, it has a Very Expensive valuation with a 6.02 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 39.42%, its profits have risen by 38.7% ; the PEG ratio of the company is 0.4
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is PharmaSGP Holding SE for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
PharmaSGP Holding SE
39.42%
0.80
32.53%
Germany DAX (TR)
18.37%
1.68
18.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.35%
EBIT Growth (5y)
8.13%
EBIT to Interest (avg)
10.08
Debt to EBITDA (avg)
1.44
Net Debt to Equity (avg)
1.00
Sales to Capital Employed (avg)
1.01
Tax Ratio
25.06%
Dividend Payout Ratio
3.04%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
111.99%
ROE (avg)
59.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
9.49
EV to EBIT
13.54
EV to EBITDA
10.16
EV to Capital Employed
5.25
EV to Sales
3.15
PEG Ratio
1.86
Dividend Yield
0.17%
ROCE (Latest)
38.74%
ROE (Latest)
54.25%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for PharmaSGP Holding SE
Net Sales - Half Yearly
At EUR 51.39 MM has Grown at 17.25 %
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (EUR MM)
Operating Profit (PBDIT) - Quarterly
Highest at EUR 9 MM. and Grown
in each of the last 5 periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (EUR MM)
Debt-Equity Ratio - Half Yearly
Lowest at 0.82 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Profit Margin - Quarterly
Highest at 36.90%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales (EUR MM)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at EUR 6 MM.
in the last five periodsMOJO Watch
Near term PBT trend is positive
PBT less Other Income (EUR MM)
Profit After Tax (PAT) - Quarterly
Highest at EUR 5 MM.
in the last five periodsMOJO Watch
Near term PAT trend is positive
PAT (EUR MM)
Cash and Cash Equivalents - Half Yearly
Highest at EUR 40.77 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents (EUR MM)
Debtors Turnover Ratio- Half Yearly
Highest at 11.33 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for PharmaSGP Holding SE
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00 %
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
